Vimarsana
Biggest News Aggregation in the World

Page 3 - Vx Premium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vx Premium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vx Premium Today - Breaking & Trending Today

Tech Times Weekly Wrap: Apple Cybersecurity Report, Grok AI on X, Meta's New XR Headset - Vimarsana News

Tech Times Weekly Wrap: Apple Cybersecurity Report, Grok AI on X, Meta's New XR Headset

Last week saw massive headlines, which include Apple, X, and Meta, with the latest developments in tech.

Grok rolled out to all X Premium+ subscribers in the US; Know all about Elon Musk's AI chatbot - Vimarsana News

Grok rolled out to all X Premium+ subscribers in the US; Know all about Elon Musk's AI chatbot

X Premium+ subscribers in the US can now access Grok, Elon Musk's AI chatbot with a “rebellious streak” on the side menu of the web, Android and iOS versions of X.

Elon Musk's xAI starts rolling out AI chatbot Grok to X's premium subscribers - Vimarsana News

Elon Musk's xAI starts rolling out AI chatbot Grok to X's premium subscribers

Grok's rollout comes amid surging user adoption for AI chatbots such as OpenAI's ChatGPT,Google's Bard and Anthropic's Claude.

Elon Musk's X Could Be Looking At Selling Old Twitter Handles For Big Money: Report - Vimarsana News

Elon Musk's X Could Be Looking At Selling Old Twitter Handles For Big Money: Report

X’s team is reportedly working on a "marketplace," which will feature purchasable old usernames for as much as $50,000. Here are the details.

Source: news18.com
Tech Times Weekly Wrap: FDA Recall for Eyedrops, Cruise Robotaxi Crash, X New Subscription Tiers - Vimarsana News

Tech Times Weekly Wrap: FDA Recall for Eyedrops, Cruise Robotaxi Crash, X New Subscription Tiers

Here is the latest update for all things in tech, featuring the top news from last week. This week on Tech Times Weekly Wrap, the massive recall of the US Food and Drug Administration (FDA) has recalled as many as 26 brands of eye drops because of an impending risk of blindness.